Apply for funding to deliver collaborative research projects to develop and test integration of quantum computing into high-performance computational workflows, enabling user access and widespread adoption.
You must be based at a UK research organisation eligible for EPSRC funding.
UK registered businesses providing flexibility services can submit an expression of interest for a trial assessing if DTU can reduce renewable electricity curtailment in Great Britain. Successful applicants can apply for a share of up to £16 million.
Apply for funding to purchase strategic infrastructure that will improve UK scientific capability and enable cutting-edge research of high priority to EPSRC.
You must be based at a UK research organisation eligible for EPSRC funding.
Join the CoSTAR Network and host national infrastructure for creative sector research and development. Reduce barriers to creative businesses’ technology adoption and support commercialisation, scale up and investment for creative tech businesses.
You must be based at a UK research organisation eligible for AHRC funding.
Join the CoSTAR Network and host national infrastructure for creative sector research and development. Reduce barriers to creative businesses’ technology adoption and support commercialisation, scale up and investment for creative tech businesses.
You must be based at a UK research organisation eligible for AHRC funding.
Apply for funding for projects focused on speculative and high-risk research with the potential to deliver a step change in the sustainability of future AI systems.
You must be based at a UK research organisation eligible for UK Research and Innovation funding.
Apply for funding to support the development of an open-source hardware security research platform to strengthen the UK’s capability to design, test and assure secure hardware.
You must be based at a UK research organisation eligible for EPSRC funding.
Innovate UK, on behalf of the OLS Cancer Healthcare Goals programme, will invest up to £25.4 million, to support the clinical validation and evaluation of early cancer diagnostic technologies and devices.